| 000 | 01756 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514222300.0 | ||
| 264 | 0 | _c20050805 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/j.bmcl.2005.01.079 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalmer, Brian D | |
| 245 | 0 | 0 |
_aStructure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Wee1. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cApr 2005 |
||
| 300 |
_a1931-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAniline Compounds _xchemistry |
| 650 | 0 | 4 | _aCSK Tyrosine-Protein Kinase |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aNaphthyridines _xchemistry |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Kinases _xdrug effects |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidinones _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _asrc-Family Kinases |
| 700 | 1 | _aSmaill, Jeff B | |
| 700 | 1 | _aRewcastle, Gordon W | |
| 700 | 1 | _aDobrusin, Ellen M | |
| 700 | 1 | _aKraker, Alan | |
| 700 | 1 | _aMoore, Charles W | |
| 700 | 1 | _aSteinkampf, Randall W | |
| 700 | 1 | _aDenny, William A | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 15 _gno. 7 _gp. 1931-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2005.01.079 _zAvailable from publisher's website |
| 999 |
_c15452549 _d15452549 |
||